LEUKOCYTE ADHESION DEFICIENCY

Clinical trials for LEUKOCYTE ADHESION DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new LEUKOCYTE ADHESION DEFICIENCY trials appear

Sign up with your email to follow new studies for LEUKOCYTE ADHESION DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Scientists track patients for 15 years after pioneering gene therapy for rare immune disease

Disease control Ongoing

This study follows 9 patients for up to 15 years after they received an experimental gene therapy for Leukocyte Adhesion Deficiency-I (LAD-I), a rare and serious immune system disorder. Researchers want to understand the long-term safety of the treatment and whether it continues …

Matched conditions: LEUKOCYTE ADHESION DEFICIENCY

Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

LEUKOCYTE ADHESION DEFICIENCY

Get alerted when new LEUKOCYTE ADHESION DEFICIENCY trials appear

Scientists track patients for 15 years after pioneering gene therapy for rare immune disease